# The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery

> **NCT02127489** · PHASE4 · COMPLETED · sponsor: **Karadeniz Technical University** · enrollment: 40 (actual)

## Conditions studied

- Failed Moderate Sedation During Procedure

## Interventions

- **DRUG:** 1 mL/kg bupivacaine 0.25%.

## Key facts

- **NCT ID:** NCT02127489
- **Lead sponsor:** Karadeniz Technical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02127489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02127489, "The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02127489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*